Bone marrow mesenchymal stem cell transplantation for treatment of cis-platinum-induced ovarian damage
10.3969/j.issn.2095-4344.2015.10.022
- VernacularTitle:骨髓间充质干细胞移植治疗顺铂致卵巢的化疗性损伤
- Author:
Xiaofeng YE
;
Yuanli HE
;
Xiafei FU
;
Xuefeng WANG
- Publication Type:Journal Article
- Keywords:
Ovarian Diseases;
Cisplatin;
Bone Marrow;
Mesenchymal Stem Cel Transplantation
- From:
Chinese Journal of Tissue Engineering Research
2015;(10):1597-1602
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUND:Chemotherapy drugs can damage the ovarian function in women of childbearing age, and even lead to premature ovarian failure. Therefore, to improve and restore the ovarian function in patients has become an important issue. OBJECTIVE:To explore the therapeutic effect and feasibility of bone marrow mesenchymal stem cel therapy against chemotherapy-induced ovarian damage. METHODS:Rat models of chemotherapy-induced premature ovarian failure were established, and injected with PKH26-labeled bone marrow mesenchymal stem cels. At 15, 30, 45, 60 days after cel transplantation, five rats were selected respectively to detect folicle-stimulating hormone and estradiol levels, and then, the rats were kiled to take the right ovary for pathological examination. The number of ovarian folicles was detected under light microscope. At 30 days after cel transplantation, another two rats were selected to mate with male rats to observe the difference in the reproductive activity. RESULTS AND CONCLUSION:Four of 22 rats (18%) gradualy recovered their estrous cycle after cel transplantation, with the decreased folicle-stimulating hormone level and increased estradiol level. Moreover, the number of folicles was reduced. Al of these indicated that the ability to have children in rats was not damaged.These experimental findings suggest that bone marrow mesenchymal stem cels can partialy improve the ovarian function of rats under chemotherapy.
